$BCRX
BIOCRYST PHARMACEUTICALS INC

2016 Q1 Form 10-Q Financial Statement

#000117184316009811 Filed on May 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $4.820M $6.826M
YoY Change -29.39% 97.4%
Cost Of Revenue $15.00K
YoY Change -78.57%
Gross Profit $4.820M $6.811M
YoY Change -29.23% 100.91%
Gross Profit Margin 100.0% 99.78%
Selling, General & Admin $3.212M $4.061M
YoY Change -20.91% 155.41%
% of Gross Profit 66.64% 59.62%
Research & Development $20.58M $17.12M
YoY Change 20.2% 86.43%
% of Gross Profit 426.95% 251.36%
Depreciation & Amortization $47.00K $45.00K
YoY Change 4.44% -15.09%
% of Gross Profit 0.98% 0.66%
Operating Expenses $23.79M $21.18M
YoY Change 12.32% 130.65%
Operating Profit -$19.05M -$14.43M
YoY Change 32.0% 95.37%
Interest Expense $1.470M $1.315M
YoY Change 11.79% 5.88%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$22.83M -$15.16M
YoY Change 50.59% 49.51%
Income Tax
% Of Pretax Income
Net Earnings -$22.83M -$15.16M
YoY Change 50.57% 49.59%
Net Earnings / Revenue -473.69% -222.15%
Basic Earnings Per Share -$0.21
Diluted Earnings Per Share -$310.2K -$0.21
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding 73.60M 72.34M

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.82M $67.50M
YoY Change -46.94% 115.03%
Cash & Equivalents $12.90M $48.37M
Short-Term Investments $22.91M $19.20M
Other Short-Term Assets $5.300M $7.000M
YoY Change -24.29% 600.0%
Inventory $1.949M $1.200M
Prepaid Expenses
Receivables $7.400M $5.600M
Other Receivables $0.00 $0.00
Total Short-Term Assets $50.43M $81.40M
YoY Change -38.05% 127.81%
LONG-TERM ASSETS
Property, Plant & Equipment $8.362M $700.0K
YoY Change 1094.57% 169.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $41.10M $41.10M
YoY Change 0.0% 1422.22%
Other Assets $2.714M $6.700M
YoY Change -59.49% 49.05%
Total Long-Term Assets $52.46M $48.50M
YoY Change 8.16% 533.49%
TOTAL ASSETS
Total Short-Term Assets $50.43M $81.40M
Total Long-Term Assets $52.46M $48.50M
Total Assets $102.9M $129.9M
YoY Change -20.8% 199.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.691M $5.300M
YoY Change 45.11% 292.01%
Accrued Expenses $17.33M $19.50M
YoY Change -11.14% 208.94%
Deferred Revenue
YoY Change
Short-Term Debt $27.90M $30.00M
YoY Change -7.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.07M $61.90M
YoY Change 1.89% 352.19%
LONG-TERM LIABILITIES
Long-Term Debt $2.500M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $9.500M $3.600M
YoY Change 163.89% -33.33%
Total Long-Term Liabilities $12.00M $3.600M
YoY Change 233.33% -89.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.07M $61.90M
Total Long-Term Liabilities $12.00M $3.600M
Total Liabilities $75.10M $65.50M
YoY Change 14.66% 33.4%
SHAREHOLDERS EQUITY
Retained Earnings -$533.7M
YoY Change
Common Stock $737.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.80M $64.40M
YoY Change
Total Liabilities & Shareholders Equity $102.9M $129.9M
YoY Change -20.8% 199.4%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$22.83M -$15.16M
YoY Change 50.57% 49.59%
Depreciation, Depletion And Amortization $47.00K $45.00K
YoY Change 4.44% -15.09%
Cash From Operating Activities -$18.84M -$3.730M
YoY Change 405.09% -58.37%
INVESTING ACTIVITIES
Capital Expenditures -$3.260M -$570.0K
YoY Change 471.93% 5600.0%
Acquisitions
YoY Change
Other Investing Activities $5.970M -$3.380M
YoY Change -276.63% 231.37%
Cash From Investing Activities $2.710M -$3.950M
YoY Change -168.61% 286.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $1.175M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 140.0K 1.500M
YoY Change -90.67% -37.55%
NET CHANGE
Cash From Operating Activities -18.84M -3.730M
Cash From Investing Activities 2.710M -3.950M
Cash From Financing Activities 140.0K 1.500M
Net Change In Cash -15.99M -6.180M
YoY Change 158.74% -18.47%
FREE CASH FLOW
Cash From Operating Activities -$18.84M -$3.730M
Capital Expenditures -$3.260M -$570.0K
Free Cash Flow -$15.58M -$3.160M
YoY Change 393.04% -64.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 bcrx Available For Sale Securities Accrued Interest
AvailableForSaleSecuritiesAccruedInterest
179000
CY2015Q4 bcrx Available For Sale Securities Accrued Interest
AvailableForSaleSecuritiesAccruedInterest
293000
CY2016Q1 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
32806000
CY2015Q4 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
28395000
CY2016Q1 bcrx Available For Sale Securities Debt Maturities Maturing After Two Years
AvailableForSaleSecuritiesDebtMaturitiesMaturingAfterTwoYears
8328000
CY2015Q4 bcrx Available For Sale Securities Debt Maturities Maturing After Two Years
AvailableForSaleSecuritiesDebtMaturitiesMaturingAfterTwoYears
19288000
CY2016Q1 bcrx Collaborative And Other Research And Development
CollaborativeAndOtherResearchAndDevelopment
2930000
CY2015Q1 bcrx Collaborative And Other Research And Development
CollaborativeAndOtherResearchAndDevelopment
4771000
CY2016Q1 bcrx Collaborative And Other Research And Development Revenues
CollaborativeAndOtherResearchAndDevelopmentRevenues
2930000
CY2015Q1 bcrx Collaborative And Other Research And Development Revenues
CollaborativeAndOtherResearchAndDevelopmentRevenues
4771000
CY2016Q1 bcrx Deferred Collaboration Expense Assets
DeferredCollaborationExpenseAssets
246000
CY2015Q4 bcrx Deferred Collaboration Expense Assets
DeferredCollaborationExpenseAssets
265000
CY2016Q1 bcrx Deferred Collaboration Expense Changes In Operating Assets And Liabilities
DeferredCollaborationExpenseChangesInOperatingAssetsAndLiabilities
-19000
CY2015Q1 bcrx Deferred Collaboration Expense Changes In Operating Assets And Liabilities
DeferredCollaborationExpenseChangesInOperatingAssetsAndLiabilities
-14000
CY2016Q1 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized For Remainder Of Fiscal Year
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedForRemainderOfFiscalYear
4840000
CY2016Q1 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Four
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearFour
1672000
CY2016Q1 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Three
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearThree
3796000
CY2016Q1 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Two
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearTwo
5856000
CY2016Q1 bcrx Lease Financing Obligation Net Of Current
LeaseFinancingObligationNetOfCurrent
2506000
CY2015Q4 bcrx Lease Financing Obligation Net Of Current
LeaseFinancingObligationNetOfCurrent
2375000
CY2016Q1 bcrx Maturity Of Investments
MaturityOfInvestments
P3Y
CY2015Q1 bcrx Maximum Aggregate Offering Price
MaximumAggregateOfferingPrice
150000000
CY2016Q1 bcrx Number Of Stockbased Compensation Plans
NumberOfStockbasedCompensationPlans
2
CY2013Q4 bcrx Remaining Aggregate Offering Price
RemainingAggregateOfferingPrice
10000000
CY2013Q4 bcrx Maximum Aggregate Offering Price
MaximumAggregateOfferingPrice
125000000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7691000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9307000
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17328000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16237000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
48000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-206000
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
560762000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
558113000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2645000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2259000
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
110000
CY2015Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
110000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1330000
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3529000
CY2016Q1 us-gaap Assets
Assets
102881000
CY2015Q4 us-gaap Assets
Assets
122359000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
50425000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
63794000
CY2016Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
64048000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
70347000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
64000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
17000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
212000
CY2016Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
63822000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
70261000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
22914000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
22664000
CY2016Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
22914000
CY2015Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
22664000
CY2016Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
41134000
CY2015Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
47683000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15024000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12902000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28899000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54540000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48367000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15997000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6173000
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73693000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73355000
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73693000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73355000
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
737000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
734000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22578000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
329000
CY2016Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9194000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9674000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
47000
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
15000
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
23868000
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
21256000
CY2016Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
90000
CY2015Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
90000
CY2016Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
313000
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
16164000
CY2016Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-2753000
CY2015Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
464000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-541000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3404000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-480000
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-359000
CY2016Q1 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-2753000
CY2015Q1 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
464000
CY2016Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1228000
CY2015Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1212000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
337000
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
527000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
313000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1848000
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
27804000
CY2016Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1141000
CY2015Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-3896000
CY2016Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
353000
CY2015Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
2487000
CY2016Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
439000
CY2015Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
117000
CY2016Q1 us-gaap Interest Expense
InterestExpense
1470000
CY2015Q1 us-gaap Interest Expense
InterestExpense
1315000
CY2016Q1 us-gaap Interest Payable Current
InterestPayableCurrent
7974000
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6746000
CY2016Q1 us-gaap Inventory Net
InventoryNet
1949000
CY2015Q4 us-gaap Inventory Net
InventoryNet
1612000
CY2016Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1949000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1612000
CY2016Q1 us-gaap Investments And Cash
InvestmentsAndCash
78915000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
102881000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
122359000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
63070000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
62257000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
138000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1501000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2707000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3948000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18842000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3726000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-22832000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-15164000
CY2016Q1 us-gaap Notes Payable Current
NotesPayableCurrent
27914000
CY2016Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
CY2015Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3378000
CY2016Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3260000
CY2015Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
565000
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3221000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19048000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-14430000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2714000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5468000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
254000
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
140000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2674000
CY2016Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Reclassifications</div></div></div><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&nbsp;</div><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">During the first quarter of 2016, the Company adopted Accounting Standards Update No. 2015-03, <div style="display: inline; font-style: italic;">Simplifying the Presentation of Debt Issuance Costs</div>. Accordingly, debt issuance costs of $2,196 classified as other current assets as of December 31, 2015 have been reclassified and netted against non-recourse notes payable to conform to the 2016 presentation.</div></div></div>
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1175000
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
6320000
CY2015Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2482000
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
326000
CY2016Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
131000
CY2015Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8362000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5149000
CY2016Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
7384000
CY2015Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
6243000
CY2016Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
0
CY2015Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
8000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20579000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17120000
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1965000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1612000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-533749000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-510917000
CY2016Q1 us-gaap Revenues
Revenues
4820000
CY2015Q1 us-gaap Revenues
Revenues
6826000
CY2016Q1 us-gaap Royalty Expense
RoyaltyExpense
77000
CY2015Q1 us-gaap Royalty Expense
RoyaltyExpense
60000
CY2016Q1 us-gaap Royalty Revenue
RoyaltyRevenue
1890000
CY2015Q1 us-gaap Royalty Revenue
RoyaltyRevenue
1518000
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
537000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
4820000
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
6826000
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3212000
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4061000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2645000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2259000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
27798000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
47724000
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&nbsp;</div><div style=" font-size: 10pt; text-indent: 27pt; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.</div></div></div>
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73601000
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72341000

Files In Submission

Name View Source Status
0001171843-16-009811-index-headers.html Edgar Link pending
0001171843-16-009811-index.html Edgar Link pending
0001171843-16-009811.txt Edgar Link pending
0001171843-16-009811-xbrl.zip Edgar Link pending
bcrx-20160331.xml Edgar Link completed
bcrx-20160331.xsd Edgar Link pending
bcrx-20160331_cal.xml Edgar Link unprocessable
bcrx-20160331_def.xml Edgar Link unprocessable
bcrx-20160331_lab.xml Edgar Link unprocessable
bcrx-20160331_pre.xml Edgar Link unprocessable
exh101_1.jpg Edgar Link pending
exh101_2.jpg Edgar Link pending
exh_101.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_050916p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending